These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25162105)

  • 1. [Paradigm shift in the treatment of rectal cancer. However, tailor-made, function-saving therapy must be systematically evaluated].
    Syk I
    Lakartidningen; 2014 Jul 2-15; 111(27-28):1172. PubMed ID: 25162105
    [No Abstract]   [Full Text] [Related]  

  • 2. Rectal Cancer: Time for Precision Medicine?
    Weiser MR
    Ann Surg Oncol; 2016 Jan; 23(1):12-5. PubMed ID: 26323994
    [No Abstract]   [Full Text] [Related]  

  • 3. Lessons Learned From the Quest for Gene Signatures That Predict Treatment Response in Rectal Cancer.
    Kalady MF
    Dis Colon Rectum; 2016 Sep; 59(9):898-900. PubMed ID: 27505120
    [No Abstract]   [Full Text] [Related]  

  • 4. Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?
    Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Camargo AA
    Dis Colon Rectum; 2016 Sep; 59(9):895-7. PubMed ID: 27505119
    [No Abstract]   [Full Text] [Related]  

  • 5. Information science ontologies and metaphysics: in regard to an umbrella protocol for standardized data collection in rectal cancer by Meldolesi et al.
    Oskan F
    Radiother Oncol; 2015 Jan; 114(1):131. PubMed ID: 25454174
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
    Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
    Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and challenges in treatment of locally advanced rectal cancer.
    Smith JJ; Garcia-Aguilar J
    J Clin Oncol; 2015 Jun; 33(16):1797-808. PubMed ID: 25918296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicine is a science of uncertainty and an art of probability (Sir W. Osler).
    Meldolesi E; van Soest J; Dinapoli N; Dekker A; Damiani A; Gambacorta MA; Valentini V
    Radiother Oncol; 2015 Jan; 114(1):132-4. PubMed ID: 25616538
    [No Abstract]   [Full Text] [Related]  

  • 9. An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine.
    Meldolesi E; van Soest J; Dinapoli N; Dekker A; Damiani A; Gambacorta MA; Valentini V
    Radiother Oncol; 2014 Jul; 112(1):59-62. PubMed ID: 24853366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neoadjuvant therapy in sphincter-saving surgery for mid and distal rectal cancer.
    Leibold T; Guillem JG
    Cancer Invest; 2010 Mar; 28(3):259-67. PubMed ID: 19857039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: Pioneering, standardization, challenges and personalization.
    Valentini V; Alfieri S; Coco C; D'Ugo D; Crucitti A; Pacelli F; Persiani R; Sofo L; Picciocchi A; Doglietto GB; Barbaro B; Vecchio FM; Ricci R; Damiani A; Savino MC; Boldrini L; Cellini F; Meldolesi E; Romano A; Chiloiro G; Gambacorta MA
    Radiother Oncol; 2024 May; 194():110190. PubMed ID: 38438019
    [No Abstract]   [Full Text] [Related]  

  • 12. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
    Denost Q; Kontovounisios C; Rasheed S; Chevalier R; Brasio R; Capdepont M; Rullier E; Tekkis PP
    Eur J Surg Oncol; 2017 Jan; 43(1):92-99. PubMed ID: 27717529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of rectal cancer after neoadjuvant chemoradiation. Where are we going?
    Caricato M; Ausania F; Coppola R
    Surg Oncol; 2007 Dec; 16 Suppl 1():S91-2. PubMed ID: 18042377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it time for a paradigm shift in early rectal cancer treatment?
    de Wilt JHW; Bach SP
    Ann Oncol; 2023 Apr; 34(4):336-338. PubMed ID: 36646319
    [No Abstract]   [Full Text] [Related]  

  • 15. Tailoring treatment of rectal adenocarcinoma: immunohistochemistry for predictive biomarkers.
    Kapur P
    Anticancer Drugs; 2011 Apr; 22(4):362-70. PubMed ID: 21233707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective on the current treatment strategies for locally advanced rectal cancer.
    Avallone A; Aloj L; Aprile G; Rosati G; Budillon A
    Int J Biochem Cell Biol; 2015 Aug; 65():192-6. PubMed ID: 26055517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [To regulate the multimodality treatment of rectal cancer with evidence-based medicine].
    Xu L; Yao HW; Liu YH
    Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):965-7. PubMed ID: 19957801
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of rectal cancer--a critical update.
    Williams NS
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):817-24. PubMed ID: 10730575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the PROSPECT trial: precision treatment for rectal cancer?
    Weiser MR; Fichera A; Schrag D; Boughey JC; You YN
    Bull Am Coll Surg; 2015 Apr; 100(4):51-2. PubMed ID: 25939207
    [No Abstract]   [Full Text] [Related]  

  • 20. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
    Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
    Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.